Characterization of pulmonary hypertension in heart failure using the diastolic pressure gradient: Limitations of a solitary measurement

JACC: Heart Failure

Volumn 3, Issue 1, 2015, Pages 17-21

  Chatterjee, Neal A ^a   Lewis, Gregory D ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Congestive heart failure; Pulmonary circulation and disease

Indexed keywords

CARDIOMYOPATHY; DIASTOLIC BLOOD PRESSURE; EDITORIAL; HEART FAILURE; HEART HEMODYNAMICS; HEART LEFT ATRIUM PRESSURE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FILLING PRESSURE; HUMAN; LUNG VASCULAR RESISTANCE; MEAN ARTERIAL PRESSURE; PRESSURE GRADIENT; PREVALENCE; PROGNOSIS; PULMONARY ARTERY OCCLUSION PRESSURE; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; VASCULAR REMODELING; COMPLICATION; FEMALE; HEART LEFT VENTRICLE FUNCTION; LUNG WEDGE PRESSURE; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR RESISTANCE;

FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; PULMONARY WEDGE PRESSURE; VASCULAR RESISTANCE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84920271794     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2014.09.002     Document Type: Editorial

References (29)

1. Simonneau G., Robbins I.M., Beghetti M., et al. Updated clinical classification of pulmonary hypertension. JAm Coll Cardiol 2009, 54:S43-S54.
2. Lam C.S., Roger V.L., Rodeheffer R.J., Borlaug B.A., Enders F.T., Redfield M.M. Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. JAm Coll Cardiol 2009, 53:1119-1126.
3. Lewis G.D., Murphy R.M., Shah R.V., et al. Pulmonary vascular response patterns during exercise in left ventricular systolic dysfunction predict exercise capacity and outcomes. Circ Heart Fail 2011, 4:276-285.
4. Fang J.C., DeMarco T., Givertz M.M., et al. WorldHealth Organization Pulmonary Hypertension group 2: pulmonary hypertension due to left heart disease in the adult-a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation. JHeart Lung Transplant 2012, 31:913-933.
5. Butler J., Chomsky D.B., Wilson J.R. Pulmonary hypertension and exercise intolerance in patients with heart failure. JAm Coll Cardiol 1999, 34:1802-1806.
6. Cappola T.P., Felker G.M., Kao W.H., Hare J.M., Baughman K.L., Kasper E.K. Pulmonary hypertension and risk of death in cardiomyopathy: patients with myocarditis are at higher risk. Circulation 2002, 105:1663-1668.
7. Franciosa J.A., Baker B.J., Seth L. Pulmonary versus systemic hemodynamics in determining exercise capacity of patients with chronic left ventricular failure. Am Heart J 1985, 110:807-813.
8. Lewis G.D., Shah R.V., Pappagianopolas P.P., Systrom D.M., Semigran M.J. Determinants of ventilatory efficiency in heart failure: the role ofright ventricular performance and pulmonary vascular tone. Circ Heart Fail 2008, 1:227-233.
9. Ghio S., Gavazzi A., Campana C., et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. JAm Coll Cardiol 2001, 37:183-188.
10. Abramson S.V., Burke J.F., Kelly J.J., et al. Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy. Ann Intern Med 1992, 116:888-895.
11. Costard-Jackle A., Fowler M.B. Influence ofpreoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. JAm Coll Cardiol 1992, 19:48-54.
12. Khush K.K., Tasissa G., Butler J., McGlothlin D., DeMarco T. Effect of pulmonary hypertension onclinical outcomes in advanced heart failure: analysis of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) database. Am Heart J 2009, 157:1026-1034.
13. Vachiery J.L., Adir Y., Barbera J.A., et al. Pulmonary hypertension due to left heart diseases. JAm Coll Cardiol 2013, 62:D100-D108.
14. Naeije R., Vachiery J.L., Yerly P., Vanderpool R. The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease. Eur Respir J 2013, 41:217-223.
15. Gerges C., Gerges M., Lang M.B., et al. Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in "out-of-proportion" pulmonary hypertension. Chest 2013, 143:758-766.
16. Sibbald W.J., Paterson N.A., Holliday R.L., Anderson R.A., Lobb T.R., Duff J.H. Pulmonary hypertension in sepsis: measurement by the pulmonary arterial diastolic-pulmonary wedge pressure gradient and the influence of passive and active factors. Chest 1978, 73:583-591.
17. Chatterjee N.A., Lewis G.D. What is the prognostic significance of pulmonary hypertension in heart failure?. Circ Heart Fail 2011, 4:541-545.
18. Tampakakis E., Leary P.J., Selby V.N., et al. The diastolic pulmonary gradient does not predict survival in patients with pulmonary hypertension due to left heart disease. JAm Coll Cardiol HF 2015, 3:9-16.
19. Bursi F., McNallan S.M., Redfield M.M., et al. Pulmonary pressures and death in heart failure: a community study. JAm Coll Cardiol 2012, 59:222-231.
20. Schwartzenberg S., Redfield M.M., From A.M., Sorajja P., Nishimura R.A., Borlaug B.A. Effects of vasodilation in heart failure with preserved or reduced ejection fraction implications of distinct pathophysiologies on response to therapy. JAm Coll Cardiol 2012, 59:442-451.
21. Harvey R.M., Enson Y., Ferrer M.I. A reconsideration of the origins of pulmonary hypertension. Chest 1971, 59:82-94.
22. Tedford R.J., Hassoun P.M., Mathai S.C., et al. Pulmonary capillary wedge pressure augments right ventricular pulsatile loading. Circulation 2012, 125:289-297.
23. Tedford R.J., Beaty C.A., Mathai S.C., et al. Prognostic value of the pre-transplant diastolic pulmonary artery pressure-to-pulmonary capillary wedge pressure gradient in cardiac transplant recipients with pulmonary hypertension. JHeart Lung Transplant 2014, 33:289-297.
24. Champion H.C., Michelakis E.D., Hassoun P.M. Comprehensive invasive and noninvasive approach to the right ventricle-pulmonary circulation unit: state of the art and clinical and research implications. Circulation 2009, 120:992-1007.
25. Stevenson L.W., Tillisch J.H., Hamilton M., et al. Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol 1990, 66:1348-1354.
26. Borlaug B.A., Nishimura R.A., Sorajja P., Lam C.S., Redfield M.M. Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction. Circ Heart Fail 2010, 3:588-595.
27. Abraham W.T., Adamson P.B., Bourge R.C., et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet 2011, 377:658-666.
28. Mehra M.R., Kobashigawa J., Starling R., et al. Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates-2006. JHeart Lung Transplant 2006, 25:1024-1042.
29. Chatterjee N.A., Upadhyay G.A., Singal G., et al. Pre-capillary pulmonary hypertension and right ventricular dilation predict clinical outcome in cardiac resynchronization therapy. JAm Coll Cardiol HF 2014, 2:230-237.